Walleye Capital’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,131
Closed -$962K 4512
2025
Q4
$961K Buy
15,131
+10,928
+260% +$680K 0.01% 2466
2025
Q3
$231K Buy
+4,203
New +$173K ﹤0.01% 3222
2025
Q2
Sell
-14,130
Closed -$491K 4614
2025
Q1
$568K Buy
+14,130
New +$649K 0.01% 2444
2024
Q3
Hold
0
5401
2024
Q2
Sell
-105,662
Closed -$6.38M 5677
2024
Q1
$7.41M Buy
105,662
+67,999
+181% +$5.26M 0.08% 1031
2023
Q4
$3.14M Buy
+37,663
New +$1.36M 0.04% 1444
2023
Q3
Sell
-25,323
Closed -$843K 5079
2023
Q2
$826K Buy
+25,323
New +$937K 0.01% 2014
2023
Q1
Sell
-214,204
Closed -$9.81M 4102
2022
Q4
$9.81M Buy
214,204
+99,560
+87% +$4.28M 0.21% 125
2022
Q3
$5.55M Buy
114,644
+29,784
+35% +$1.43M 0.13% 210
2022
Q2
$3.33M Buy
84,860
+6,580
+8% +$265K 0.1% 244
2022
Q1
$2.88M Buy
+78,280
New +$2.78M 0.08% 268
2020
Q2
Sell
-31,515
Closed -$372K 686
2020
Q1
$372K Buy
31,515
+65
+0.2% +$829 0.11% 288
2019
Q4
$333K Buy
+31,450
New +$323K 0.07% 870
2019
Q3
Sell
-9,600
Closed -$108K 2051
2019
Q2
$108K Buy
+9,600
New +$92.6K 0.11% 1202

Other funds holding CYTK